VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 93 filers reported holding VERVE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,055,509 | -29.1% | 79,602 | +0.3% | 0.00% | -50.0% |
| Q2 2023 | $1,488,431 | +143709.8% | 79,383 | +10.6% | 0.00% | +100.0% |
| Q1 2023 | $1,035 | -21.3% | 71,794 | +5.7% | 0.00% | -50.0% |
| Q4 2022 | $1,315 | -99.9% | 67,933 | +6.0% | 0.00% | -33.3% |
| Q3 2022 | $2,201,000 | +183.6% | 64,067 | +26.2% | 0.00% | +200.0% |
| Q2 2022 | $776,000 | -8.1% | 50,763 | +37.3% | 0.00% | 0.0% |
| Q1 2022 | $844,000 | +28.5% | 36,980 | +107.5% | 0.00% | 0.0% |
| Q4 2021 | $657,000 | -20.7% | 17,824 | +1.0% | 0.00% | 0.0% |
| Q3 2021 | $829,000 | – | 17,640 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $515,778,000 | 12.24% |
| Casdin Capital, LLC | 3,038,167 | $142,794,000 | 3.55% |
| Redmile Group, LLC | 1,869,030 | $87,844,000 | 1.53% |
| Logos Global Management LP | 443,265 | $20,833,000 | 1.50% |
| Novo Holdings A/S | 600,000 | $28,200,000 | 1.46% |
| Cormorant Asset Management, LP | 709,224 | $32,667,000 | 1.33% |
| Rock Springs Capital Management LP | 962,826 | $45,253,000 | 0.95% |
| HighVista Strategies LLC | 18,782 | $883,000 | 0.58% |
| RA Capital Management | 880,284 | $41,373,000 | 0.57% |
| Nicholas Investment Partners, LP | 132,300 | $6,218,000 | 0.45% |